Zelluna

Zelluna company information, Employees & Contact Information

Explore related pages

Related company profiles:

Zelluna Immunotherapy is a company pioneering the development of allogeneic T cell receptor (TCR) guided natural killer (NK) cell immunotherapies for the treatment of solid cancers. The company is developing a portfolio of tumor specific TCRs to guide NK cells with the aim to induce cancer responses that are safe, efficient and durable. For more info please visit www.zelluna.com

Company Details

Employees
30
Founded
-
Address
Manager Jobs
Phone
47 22 84 00 80
Email
po****@****una.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Looking for a particular Zelluna employee's phone or email?

Zelluna Questions

News

Zelluna ASA Reports Second Quarter 2025 Financial Results and Provides General Business Update - Yahoo Finance

Zelluna ASA Reports Second Quarter 2025 Financial Results and Provides General Business Update Yahoo Finance

Zelluna Announces Investor Forum on Science & Strategy to be held on Wednesday 17 September 2025 - GlobeNewswire

Zelluna Announces Investor Forum on Science & Strategy to be held on Wednesday 17 September 2025 GlobeNewswire

Zelluna Receives Positive MHRA Feedback and Strengthens UK - GlobeNewswire

Zelluna Receives Positive MHRA Feedback and Strengthens UK GlobeNewswire

Zelluna Reaches Major Milestone with Manufacturing Process Established in Preparation for Clinical Entry of ZI-MA4-1, its Novel TCR-NK Therapy Targeting Solid Tumours - Yahoo Finance

Zelluna Reaches Major Milestone with Manufacturing Process Established in Preparation for Clinical Entry of ZI-MA4-1, its Novel TCR-NK Therapy Targeting Solid Tumours Yahoo Finance

Zelluna ASA [ZLNA]: The first ever cell therapy company to - GlobeNewswire

Zelluna ASA [ZLNA]: The first ever cell therapy company to GlobeNewswire

Zelluna Receives Positive MHRA Feedback and Strengthens UK Clinical Strategy for ZI-MA4-1 Paving the Way for First-in-Human Trials in the UK - Yahoo! Finance UK

Zelluna Receives Positive MHRA Feedback and Strengthens UK Clinical Strategy for ZI-MA4-1 Paving the Way for First-in-Human Trials in the UK Yahoo! Finance UK

Zelluna Immunotherapy - SelectScience

Zelluna Immunotherapy SelectScience

Former Immunocore and GSK researcher named Zelluna CSO - The Pharma Letter

Former Immunocore and GSK researcher named Zelluna CSO The Pharma Letter

Zelluna Immunotherapy Raises €7.5M in Funding - FinSMEs

Zelluna Immunotherapy Raises €7.5M in Funding FinSMEs

Zelluna appoints Miguel Forte as CEO - PMLiVE

Zelluna appoints Miguel Forte as CEO PMLiVE

Top Zelluna Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant